InvestorsHub Logo
Followers 16
Posts 1063
Boards Moderated 0
Alias Born 09/01/2019

Re: aGuyUS post# 28684

Monday, 11/02/2020 12:19:03 AM

Monday, November 02, 2020 12:19:03 AM

Post# of 44690
Given that the DSMC said to finish Trials and so far no EUA, the price $1.6B is fair. IMO, fwiw...
Rumors of processing the EUA and strong data are known. Yes, GEM has a big say and finances both and Wants a profit, asap, maybe already i$-ha$. RLF has $30+M on the books for those 400m shares to GEM.
So still we dont know how this will fit together thru approval(s?), delayed completions and readouts of IV and Inhaler Trials, production, sales (except profit splits when/if) and then distribution logistics and IPO of sister to NYSE BigPharma.
Question. What relevance is there between NRX101 and RLF100.